ReviewUrolithiasis2025
Recent developments in the study of cellular inflammation in the papillae of stone formers.
Review in Urolithiasis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Validation of a Renal Papillary Grading System: Comparison of Patients Forming Calcium Oxalate and Apatite Stones.Journal of endourology · 2026Article
- Construction of a LASSO regression-based predictive model for recurrence of urinary tract stones.Translational andrology and urology · 2026Article
- Inverse association between the C-reactive protein-to-albumin-to-lymphocyte (CALLY) index and kidney stones in US adults: a population-based study.Urolithiasis · 2026Article
- Scanning electron microscopy and energy dispersive spectroscopy of Randall's plaque stones: an unexpected finding of monosodium urate crystals.Urolithiasis · 2025Article
- Oxidative stress, inflammation and kidney stones.Urolithiasis · 2025Article
- Identification of aging-related biomarkers and immune infiltration analysis in renal stones by integrated bioinformatics analysis.Scientific reports · 2025Article
- The advanced lung cancer inflammation index as a predictor of kidney stone risk in men: a cross-sectional analysis.Frontiers in nutrition · 2025Article
- Research progress on the mechanisms of interleukin and chemokine families in driving calcium oxalate nephrolithiasis formation.Frontiers in immunology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Kidney stone disease has long been thought to involve tissue inflammation, but direct evidence linking inflammation as a causative factor in human stone formation remains limited. This review focuses on studies in human stone formers, highlighting variation in stone former phenotypes. Histological and molecular studies of kidney tissues reveal increased immune cell density and gene expression changes in stone formers, with notable differences between calcium oxalate and brushite stone pathologies. Phenotyping stone formers by tissue mineralization patterns-such as Randall's plaque or ductal plugging-shows significant heterogeneity in tissue damage, and thus presumably also inflammation. Systemic markers, such as elevated serum C-reactive protein, suggest a link between active stone disease and inflammation, although relationships vary with age, gender, and comorbidities. Such systemic markers have not been studied well in stone formers separated by phenotype. These insights underline the importance of stratifying patients by stone type and tissue pathology to identify inflammation pathways specific to each phenotype. Such an approach may pave the way for targeted anti-inflammatory therapies to reduce recurrence in this heterogeneous disease.
Indexed as
Identifiers
39960517What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.